Highlights
Marken: COVID-19 shaking up clinical trial supply chain
With the pandemic causing unprecedented global interruptions to the clinical trial supply chain, the logistics company s
First Wave BioPharma to Present at the DealFlow MicroCap Conference
BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FW
ANI Pharmaceuticals Announces the Launch of Pentoxifylline Extended-Release Tablets, USP
BAUDETTE, Minn., Jan. 23, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Co
Pharma manufacturer Gerresheimer gives Georgia an $88 million injection of funds
Manufacturer for the pharma and life sciences industry, Gerresheimer, is investing more than $88 million to expand its o
1MED unveils how to navigate 2024 MDR at Outsourcing in Clinical Trials Europe
1MED, a Contract Research Organisation providing clinical and regulatory support to medical devices companies, is
Running on empty: The hidden dangers of poor nutrition advice for athletes
Experts warn of short-term performance impact and long-term health risks as new research reveals poor nutrition support
Probiotic Bulgarian yogurt ‘feasible’ to achieve good health and well-being o
Freshly made Bulgarian yogurt can feasibly be incorporated into an astronaut's diet to boost gut health and overall
HEPHAISTOS-Pharma secures a €2 million seed round with xista science ventures, Found
HEPHAISTOS-Pharma secures a €2 million seed round with xista sc
HEPHAISTOS-Pharma sécurise un tour de table de €2 millions avec xista science ven
HEPHAISTOS-Pharma sécurise un tour de table de €2 millions a
German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch The
German Pain Association (DGS) and Pharmaceutical Company Avextra Join Forces to Launch Their New Study OCEAN
2024 Health IT trends in India: Expanded healthcare AI applications
Aside from clinical decision and diagnosis support, AI technology is also anticipated to assist with personalised treatm
Ex dividend NOK 0.75 today
The shares in Vistin Pharma ASA will be traded ex dividend NOK 0.75 as from today, 23.01.2024.